1. Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
- Author
-
Salim Shafeek, Yash Dilip Nilak, Zbigniew Rudzki, Joanne Chapman, and Anjumara Nilak
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,Nodular sclerosing Hodgkin's lymphoma ,lcsh:R895-920 ,Treatment failure ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,hemic and lymphatic diseases ,medicine ,Radiology, Nuclear Medicine and imaging ,Histiocyte-rich pseudotumor ,Histiocyte ,Chemotherapy ,medicine.diagnostic_test ,business.industry ,Tumor necrosis ,Hodgkin's lymphoma ,medicine.disease ,Nodular lymphocyte predominant Hodgkin's lymphoma ,Lymphoma ,stomatognathic diseases ,PET ,Oncology ,Positron emission tomography ,Post treatment ,business ,030217 neurology & neurosurgery - Abstract
Benign xanthomatous pseudotumors are rare, mass forming lesions composed of lipid laden histiocytes and tumor necrosis following chemotherapy.We present a rare case of young 36 year old male with primary mediastinal Hodgkin's lymphoma who developed xanthomatous pseudotumor mimicking relapse at the site of original disease on positron emission tomography. This scenario places emphasis on histologic confirmation of suspected treatment failure or relapse. Keywords: Nodular sclerosing Hodgkin's lymphoma, Tumor necrosis, Histiocyte-rich pseudotumor, PET
- Published
- 2020